Aesculap Biologics, LLC

PA · United States · Reporting entity ID 100000005660

Total reported 2019–2025

$7.10M

#594 of 2,960 reporting companies — 0% of all reported industry payments

$125K in general payments across 414 records, plus $6.97M in research funding across 1,158 records.

How it breaks down

General payments $125,456

Research funding $6,973,338

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.